This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on July 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
TURBOVAP LV EVAPORATION SYSTEM (2EA)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract seeks the procurement of two TurboVAP LV Evaporation Systems designed for high-throughput, reproducible, and efficient removal of organic solvents from extracted samples during laboratory sample preparation. These systems are critical for concentrating analytes prior to instrumental analysis, enhancing overall laboratory efficiency by minimizing manual handling time and ensuring consistent sample concentration across batches. The equipment must deliver reliable performance under routine operational conditions to support analytical workflows with precision and throughput. The solicitation, identified as FDA-HFP-2026-134777, was posted on July 31, 2026, with responses due by August 10, 2026. It is classified as a combined solicitation with no set-aside program applied, and falls under NAICS code 334516 for laboratory analytical instrument manufacturing. The contracting office is the FDA Office of Acq Grant Svcs under the Department of Health and Human Services, headquartered in Rockville, Maryland. The place of performance is listed as a location in Colorado, and the primary point of contact is Rodney D. Aytch, reachable via phone or email for inquiries related to the procurement.
General Info
Agency
NAICS
Place of Performance
18888, CO, USASet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
The purpose of this procurement is to acquire two (2) solvent evaporation systems capable of high-throughput, reproducible, and efficient solvent evaporation during sample preparation. The systems shall be used to remove organic solvents from extracted samples, leaving concentrated residues for further analytical processing. The equipment shall improve laboratory efficiency, reduce analyst handling time, and ensure consistent analyte concentration prior to instrumental analysis.
More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
